Skip to main content
SpringerLink
Log in

Metformin Extended Release

Metformin Gastric Retention, Metformin GR, Metformin XR

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Biovail Corporation, Depomed Inc. Biovail and Depomed Submit NDA for Glumetza — Metformin GR; Submission Includes 500mg and 1000mg Dosages. Media Release: 28 Apr 2004. Available from URL: http://www.depomedinc.com

    Google Scholar 

  2. Biovail Corporation, Depomed Inc. Biovail, Depomed Receive Approvable Letter from FDA for Extended-Release Glumetza for Type II Diabetes. Media Release: 1 Mar 2005. Available from URL: http://www.biovail.com

    Google Scholar 

  3. Biovail Corporation, Depomed Inc. Biovail, Depomed Receive FDA Approval for Extended-Release Glumetza for Type II Diabetes; Enhanced Formulation to Offer Physicians Potential Advantages. Media Release: 3 Jun 2005. Available from URL: http://www.biovail.com

    Google Scholar 

  4. Depomed Inc. Depomed Receives $25 Million from Biovail. Media Release: 6 Jul 2005. Available from URL: http://www.depomedinc.com

    Google Scholar 

  5. Biovail Corporation, Depomed Inc. Depomed, Biovail Update Status of Glumetza NDA. Media Release: 13 Apr 2005. Available from URL: http://www.depomedinc.com

    Google Scholar 

  6. Biovail Corporation, Depomed Inc. Biovail, Depomed Announce Glumetza NDA Accepted by FDA. Media Release: 24 Jun 2004. Available from URL: http://www.biovail.com

    Google Scholar 

  7. Biovail Corporation. Biovail, Depomed Announce Regulatory Approval of Glumetza to Treat Type II Diabetes in Canada. Media Release: 1 Jun 2005. Available from URL: http://www.biovail.com

    Google Scholar 

  8. Depomed Inc. Depomed Expands Patent Portfolio for Drug Delivery Technology. Media Release: 11 May 2004. Available from URL: http://www.depomedinc.com

    Google Scholar 

  9. Biovail Corporation, Depomed Inc. Biovail and Depomed Announce Glumetza NDS Acceptance. Media Release: 10 Aug 2004. Available from URL: http://www.biovail.com

    Google Scholar 

  10. Gorsline J, Gusler G, Levy G, et al. Pharmacokinetics of metformin gastric-retentive tablets in healthy volunteers. Journal of Clinical Pharmacology 41: 655–661, Jun 2001

    Article  PubMed  Google Scholar 

  11. Biovail Corporation, DepoMed Inc. DepoMed and Biovail Report Positive Phase III Clinical Results for Metformin GR Extended Release Formulation. Media Release: 3 Feb 2003. Available from URL: http://www.depomedinc.com

    Google Scholar 

  12. Biovail Corporation, Depomed Inc. Depomed and Biovail Report Positive Phase III Results with Metformin GR for Diabetes. Media Release: 10 Dec 2003. Available from URL: http://www.depomedinc.com

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Metformin Extended Release. Drugs R D 6, 316–319 (2005). https://doi.org/10.2165/00126839-200506050-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200506050-00009

Keywords

Search

Navigation